Rhiz functions to re‐sensitize AR‐V7‐positive prostate cancer cells to enzalutamide, while SINT1 inhibited prostate cancer cell growth by binding to the activation function‐1 (AF‐1) region in the NTD of AR. The gene discussed is AR; the disease is prostate carcinoma.